Biotronik, a manufacturer of cardiovascular medical technology, announced it has received approval from the According to a release, Biotronik follows this milestone with the launch of its next generation unique technology platform Ilesto DX.
Ilesto DX offers the established benefits of the DX System in a thinner and smaller device, the company said. The new electromechanical platform allows for a 15 percent size reduction and 29 percent fewer components with no compromise in longevity or clinical features.
"Demand for the DX System has led us to prioritize Ilesto DX as the first device launched as part of the new Ilesto family," said
For conventional ICD systems, providing atrial diagnostic capabilities means placing two wires (leads) in the heart, which can increase the likelihood of complications. The second alternative, a typical single-chamber (single-lead) ICD, has no sensing capability in the atrium and is therefore less equipped to detect silent high atrial rates that may cause stroke and inappropriate shocks, the company added.
"In the past, I preferred dual-chamber devices because I value the atrial information. With the DX, I no longer have to make that choice," said Dr.
"The system's sensing capabilities in combination with Biotronik Home Monitoring allows me to rapidly and continuously monitor how well the device is performing - which offers reassurance to both me and the patient," said Dr.
"Through advanced design and the use of robotic manufacturing, Biotronik has developed a highly automated production process for the electronic module," said
((Comments on this story may be sent to email@example.com))
Biotronik, a manufacturer of cardiovascular medical technology, announced it has received approval from the
According to a release, Biotronik follows this milestone with the launch of its next generation unique technology platform Ilesto DX.